Vicarious Surgical (RBOT) Interest Coverage Ratio (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Interest Coverage Ratio came in at 0.68 in Q3 2025, up 90.44% year-on-year from 0.36 in Q3 2024, and up 87.08% on a QoQ basis from 5.25 in Q2 2025.
Vicarious Surgical (RBOT) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Interest Coverage Ratio data on file, last reported at 0.68 in Q3 2025.
- On a quarterly basis, Interest Coverage Ratio rose 90.44% year-over-year to 0.68 in Q3 2025; TTM through Sep 2025 was 3.29, a 87.74% increase from a year earlier, with the FY2024 full-year figure at 0.74, up 33.5% from the prior year.
- Interest Coverage Ratio for Q3 2025 stood at 0.68, up from 5.25 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for RBOT reached as high as 9.84 in Q4 2023 and fell as low as 5231.0 in Q1 2021.
- Historically, Interest Coverage Ratio has averaged 458.67 across 5 years, with a median of 28.59 in 2022.
- Across the five-year window, Interest Coverage Ratio slumped 24895.89% in 2021 and surged 116.95% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 1370.77 in 2021, then jumped by 95.76% to 58.06 in 2022, then jumped by 116.95% to 9.84 in 2023, then sank by 364.2% to 26.0 in 2024, then soared by 97.39% to 0.68 in 2025.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.68 in Q3 2025, 5.25 in Q2 2025, and 27.34 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.68 |
| Jun 30, 2025 | -5.25 |
| Mar 31, 2025 | -27.34 |
| Dec 31, 2024 | -26.00 |
| Sep 30, 2024 | -7.10 |
| Jun 30, 2024 | -2.00 |
| Mar 31, 2024 | -28.87 |
| Dec 31, 2023 | 9.84 |
| Sep 30, 2023 | -3.29 |
| Jun 30, 2023 | -1.40 |
| Mar 31, 2023 | -45.73 |
| Dec 31, 2022 | -58.06 |
| Sep 30, 2022 | -714.90 |
| Jun 30, 2022 | -28.59 |
| Mar 31, 2022 | -71.02 |
| Dec 31, 2021 | -1,370.77 |
| Sep 30, 2021 | -276.16 |
| Jun 30, 2021 | -826.50 |
| Mar 31, 2021 | -5,231.00 |
| Dec 31, 2020 | -5.48 |